Kairos Pharma, Ltd. (NYSE American: KAPA), a clinical stage biopharmaceutical company, today provides a letter to stockholders from CEO John Yu, M.D.: ...

Hackers stole personal juvenile case histories and sensitive documents from the Baltimore City state's attorney's office in ...

This funding has directly supported the launch of our high school this year, which is building out a college-like hybrid ...

Google and Kairos Power are collaborating to build small modular reactors to provide nuclear power to data centers to give ...

The traffic at the end of a school day at Kairos Public School could be described as a nightmare on Elm Street. At the center ...

Borderlands 4's new planet, Kairos, is the perfect chance to add meaningful base building that deepens player expression ...

Kairos IMS redefines the future for nonprofits, empowering them with cutting-edge tools to fuel social impact and transform community car ...

The stage is set for a Littleton redevelopment play following a $14 million deal. Texas-based apartment developer Quarterra and New Jersey investor PGIM Real Estate purchased the 15-acre site of a ...

Home rental company Kairos Living continues to grow its presence in Livingston Parish, recently acquiring six residential lots in Denham Springs. The company purchased the lots in the South Haven ...

Kairos Pharma, Ltd. (NYSE American: KAPA) is a clinical stage company involved in treating EGFR-driven lung cancer patients with ENV105 in combination with osimertinib after they fail to respond to ...